查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| ALKS Alkermes plc Ordinary Shares | 1.27 2026-12-31 | 0.24 – 2.25 | 4 | +3.33% | +29.57% | — | 0 / 0 | $1.82B |
| FORM FormFactor Inc. FormFactor Inc. Common Stock | 3.06 2026-12-31 | 3.03 – 3.12 | 7 | +25.44% | +25.44% | +25.44% | 5 / 0 | $1.03B |
| HLIT Harmonic Inc. Common Stock | 0.38 2026-12-31 | 0.34 – 0.42 | 3 | +13.86% | +13.86% | -25.32% | 2 / 1 | $486.88M |
| REGN Regeneron Pharmaceuticals Inc. Common Stock | 50.38 2026-12-31 | 45.77 – 58.33 | 20 | +9.87% | +9.01% | +8.63% | 0 / 1 | $16.66B |
| THRM Gentherm Inc Common Stock | 2.92 2026-12-31 | 2.75 – 3.06 | 6 | +7.50% | +7.73% | +9.69% | 6 / 0 | $1.61B |
| GRC Gorman-Rupp Company (The) Common Stock | 2.81 2026-12-31 | 2.67 – 2.98 | 3 | +6.71% | +6.71% | +7.05% | 1 / 0 | $723.73M |
| GRMN Garmin Ltd. Common Stock (Switzerland) | 10.06 2026-12-31 | 10 – 10.25 | 5 | +5.02% | +5.02% | +6.13% | 3 / 2 | $8.1B |
| FHI Federated Hermes Inc. Common Stock | 5.29 2026-12-31 | 5.25 – 5.36 | 4 | -0.13% | +4.85% | +5.85% | 1 / 0 | $1.97B |
| GABC German American Bancorp Inc. Common Stock | 3.93 2026-12-31 | 3.9 – 3.96 | 5 | +4.93% | +4.47% | +4.41% | 2 / 3 | $405.3M |
| WST West Pharmaceutical Services Inc. Common Stock | 8.94 2026-12-31 | 8.58 – 9.05 | 16 | +2.73% | +3.78% | +3.66% | 1 / 1 | $3.37B |
| FMNB Farmers National Banc Corp. Common Stock | 1.68 2026-12-31 | 1.66 – 1.7 | 3 | +3.50% | +3.50% | +3.50% | 1 / 2 | $269.75M |
| HRMY Harmony Biosciences Holdings Inc. Common Stock | 4.52 2026-12-31 | 3.38 – 5.35 | 4 | +0.59% | +2.99% | +1.07% | 0 / 2 | $1.02B |
| ZGN Ermenegildo Zegna N.V. Ordinary Shares | 0.43 2026-12-31 | 0.39 – 0.49 | 11 | +2.98% | +2.85% | +4.98% | 4 / 1 | $2.03B |
| RMBS Rambus Inc. Common Stock | 3.03 2026-12-31 | 3 – 3.07 | 8 | +3.07% | +2.75% | +2.54% | 1 / 0 | $824.99M |
| ARM Arm Holdings plc American Depositary Shares | 2.23 2027-03-31 | 2.06 – 2.42 | 33 | +2.36% | +2.24% | +3.74% | 5 / 3 | $6.05B |
| RPRX Royalty Pharma plc Class A Ordinary Shares | 5.23 2026-12-31 | 5.05 – 5.33 | 6 | +2.07% | +2.15% | +2.60% | 4 / 1 | $3.47B |
| AWI Armstrong World Industries Inc Common Stock | 8.44 2026-12-31 | 8.35 – 8.5 | 10 | +1.56% | +1.48% | +1.47% | 5 / 4 | $1.79B |
| TRMK Trustmark Corporation Common Stock | 3.95 2026-12-31 | 3.9 – 4.07 | 5 | +0.92% | +1.05% | +1.05% | 5 / 0 | $848.5M |
| FWONK Liberty Media Corporation Series C Liberty Formula One Common Stock | 1.8 2026-12-31 | 1.35 – 2.46 | 6 | +0.75% | +1.03% | +10.05% | 4 / 1 | $4.72B |
| TMO Thermo Fisher Scientific Inc Common Stock | 25.11 2026-12-31 | 24.88 – 25.26 | 25 | +1.03% | +1.02% | +0.92% | 2 / 1 | $47.84B |
| KMX CarMax Inc | 2.73 2027-02-28 | 2.46 – 3.16 | 14 | +0.92% | +0.98% | +16.23% | 8 / 1 | $27.09B |
| KRMN Karman Holdings Inc. Common Stock | 0.58 2026-12-31 | 0.46 – 0.64 | 10 | 0.00% | +0.94% | -12.27% | 1 / 0 | $731.64M |
| LGND Ligand Pharmaceuticals Incorporated Common Stock | 9.18 2026-12-31 | 8.79 – 9.68 | 8 | +0.30% | +0.91% | +6.33% | 2 / 2 | $289.77M |
| INDV Indivior Pharmaceuticals Inc. Common Stock | 3.85 2026-12-31 | 3.63 – 4.05 | 5 | +0.78% | +0.78% | +23.49% | 4 / 0 | $1.26B |
| AMRX Amneal Pharmaceuticals Inc. Class A Common Stock | 0.99 2026-12-31 | 0.94 – 1.03 | 5 | +1.43% | +0.64% | -0.35% | 2 / 1 | $3.14B |
| COLL Collegium Pharmaceutical Inc. Common Stock | 7.76 2026-12-31 | 7.29 – 8.18 | 4 | +0.58% | +0.58% | +5.19% | 4 / 1 | $869.86M |
| ANIP ANI Pharmaceuticals Inc. | 9.42 2026-12-31 | 9.19 – 9.68 | 8 | +0.11% | +0.58% | +3.83% | 7 / 0 | $1.12B |
| ARMK Aramark Common Stock | 2.25 2026-09-30 | 2.19 – 2.34 | 15 | +0.21% | +0.20% | +1.26% | 0 / 3 | $19.97B |
| ALRM Alarm.com Holdings Inc. Common Stock | 2.78 2026-12-31 | 2.67 – 2.82 | 6 | +0.13% | +0.13% | -0.48% | 1 / 0 | $1.07B |
| RMD ResMed Inc. Common Stock | 11.12 2026-06-30 | 10.98 – 11.24 | 12 | +0.16% | +0.12% | +0.95% | 1 / 0 | $5.65B |
| TRMB Trimble Inc. Common Stock | 3.59 2026-12-31 | 3.53 – 3.69 | 13 | +0.09% | +0.09% | +1.26% | 12 / 1 | $3.89B |
| IRM Iron Mountain Incorporated (Delaware)Common Stock REIT | 2.43 2026-12-31 | 2.23 – 2.64 | 6 | +0.07% | +0.07% | +5.20% | 6 / 0 | $7.92B |
| ORA Ormat Technologies Inc. Common Stock | 2.26 2026-12-31 | 1.75 – 2.59 | 11 | -1.23% | +0.07% | -0.07% | 4 / 5 | $1.15B |
| CRM Salesforce Inc. Common Stock | 14.13 2027-01-31 | 13.22 – 15.28 | 51 | +0.04% | +0.03% | +7.06% | 44 / 0 | $46.11B |
| DORM Dorman Products Inc. Common Stock | 8.28 2026-12-31 | 8.1 – 8.4 | 8 | 0.00% | 0.00% | +0.02% | 2 / 4 | $2.29B |
| GRDN Guardian Pharmacy Services Inc. Class A Common Stock | 1.26 2026-12-31 | 1.2 – 1.34 | 6 | 0.00% | 0.00% | +2.94% | 3 / 0 | $1.41B |
| RMAX RE/MAX Holdings Inc. Class A Common Stock | 1.29 2026-12-31 | 1.23 – 1.35 | 3 | 0.00% | 0.00% | -1.10% | 2 / 0 | $295.15M |
| RMNI Rimini Street Inc. (DE) Common Stock | 0.38 2026-12-31 | 0.38 – 0.39 | 3 | 0.00% | 0.00% | -7.26% | 0 / 2 | $440.89M |
| SUPN Supernus Pharmaceuticals Inc. Common Stock | 2.49 2026-12-31 | 2.11 – 2.95 | 3 | 0.00% | 0.00% | +6.27% | 0 / 0 | $867.18M |
| VRRM Verra Mobility Corporation Class A Common Stock | 1.23 2026-12-31 | 1.19 – 1.31 | 8 | 0.00% | 0.00% | -9.21% | 0 / 8 | $988.75M |
| FIS Fidelity National Information Services Inc. Common Stock | 6.27 2026-12-31 | 6.07 – 6.4 | 27 | -0.03% | -0.01% | +0.14% | 13 / 5 | $13.8B |
| SFM Sprouts Farmers Market Inc. Common Stock | 5.56 2026-12-31 | 5.36 – 5.62 | 9 | +0.22% | -0.03% | +0.10% | 8 / 3 | $9.49B |
| HRL Hormel Foods Corporation Common Stock | 1.49 2026-10-31 | 1.48 – 1.51 | 9 | 0.00% | -0.04% | +1.60% | 8 / 0 | $12.28B |
| BMRN BioMarin Pharmaceutical Inc. Common Stock | 4.93 2026-12-31 | 4.86 – 5.03 | 17 | -0.10% | -0.05% | -7.84% | 1 / 0 | $3.87B |
| PRMB Primo Brands Corporation Class A Common Stock | 1.28 2026-12-31 | 1.14 – 1.46 | 11 | -0.09% | -0.09% | -2.06% | 3 / 8 | $6.78B |
| PR Permian Resources Corporation Class A Common Stock | 1.95 2026-12-31 | 1.53 – 2.3 | 18 | +0.83% | -0.15% | +4.97% | 1 / 2 | $6.21B |
| MKC McCormick & Company Incorporated Common Stock | 3.09 2026-11-30 | 3.05 – 3.13 | 13 | -0.02% | -0.17% | -0.31% | 1 / 8 | $7.89B |
| JAZZ Jazz Pharmaceuticals plc Common Stock (Ireland) | 25.31 2026-12-31 | 24.38 – 26.99 | 17 | -0.30% | -0.32% | +4.79% | 0 / 1 | $4.51B |
| ARR ARMOUR Residential REIT Inc. | 2.91 2026-12-31 | 2.89 – 2.94 | 6 | -0.73% | -0.48% | -0.59% | 0 / 1 | $315M |
| CRMD CorMedix Inc. Common Stock | 0.5 2026-12-31 | 0.44 – 0.56 | 5 | +0.80% | -0.53% | -35.85% | 3 / 3 | $334.57M |
| AFRM Affirm Holdings Inc. Class A Common Stock | 3.08 2026-06-30 | 2.47 – 3.56 | 8 | -0.44% | -0.59% | -1.50% | 5 / 1 | $4.2B |
| PFGC Performance Food Group Company Common Stock | 4.58 2026-06-30 | 4.16 – 5.23 | 14 | +0.01% | -0.74% | -0.81% | 0 / 1 | $67.92B |
| RIGL Rigel Pharmaceuticals Inc. Common Stock | 2.89 2026-12-31 | 0.64 – 4.01 | 4 | -0.77% | -0.77% | -39.72% | 0 / 1 | $278.89M |
| VRTX Vertex Pharmaceuticals Incorporated Common Stock | 18.98 2026-12-31 | 17.61 – 19.85 | 20 | +0.07% | -0.88% | -0.61% | 14 / 10 | $13.05B |
| AUPH Aurinia Pharmaceuticals Inc Ordinary Shares | 0.95 2026-12-31 | 0.85 – 1.04 | 5 | -1.04% | -1.04% | +21.28% | 1 / 0 | $325.82M |
| REPX Riley Exploration Permian Inc. Common Stock | 6.2 2026-12-31 | 5.96 – 6.42 | 5 | +0.96% | -1.99% | +13.05% | 0 / 0 | $581.75M |
| META Meta Platforms Inc. Class A Common Stock | 32.12 2026-12-31 | 30.45 – 36.62 | 52 | -2.86% | -2.29% | -0.42% | 3 / 0 | $254.08B |
| ASND Ascendis Pharma A/S Ordinary Share | 11.73 2026-12-31 | 4.11 – 16.83 | 4 | -0.72% | -2.43% | +316.13% | 0 / 0 | $1.34B |
| AMPH Amphastar Pharmaceuticals Inc. Common Stock | 2.6 2026-12-31 | 2.26 – 2.94 | 7 | -0.87% | -2.88% | -20.36% | 0 / 1 | $746.37M |
| PRM Perimeter Solutions SA Common Stock | 1.61 2026-12-31 | 1.5 – 1.68 | 3 | -3.23% | -2.97% | +13.61% | 1 / 0 | $887.41M |
| ALNY Alnylam Pharmaceuticals Inc. Common Stock | 9.09 2026-12-31 | 8.22 – 9.92 | 12 | -3.58% | -3.55% | -1.98% | 0 / 1 | $5.58B |
| TEVA Teva Pharmaceutical Industries Limited American Depositary Shares | 2.14 2026-12-31 | 1.91 – 2.94 | 12 | -0.78% | -3.63% | -10.64% | 0 / 4 | $16.58B |
| ACAD ACADIA Pharmaceuticals Inc. Common Stock | 0.37 2026-12-31 | 0.27 – 0.51 | 13 | 0.00% | -4.07% | -24.73% | 0 / 1 | $1.24B |
| KNSA Kiniksa Pharmaceuticals International plc Class A Ordinary Shares | 1.13 2026-12-31 | 1.07 – 1.18 | 3 | -2.30% | -5.56% | -3.96% | 0 / 0 | $993.71M |
| STC Stewart Information Services Corporation Common Stock | 5.52 2026-12-31 | 5.06 – 5.8 | 3 | -7.22% | -8.25% | -10.34% | 0 / 1 | $3.55B |
| SSRM SSR Mining Inc. Common Stock | 4.11 2026-12-31 | 3.36 – 5.08 | 10 | -1.21% | -8.71% | +0.40% | 2 / 4 | $2.25B |
| FRME First Merchants Corporation Common Stock | 3.86 2026-12-31 | 3.75 – 3.96 | 6 | -9.31% | -9.06% | -8.81% | 2 / 0 | $805.79M |
| RM Regional Management Corp. Common Stock | 4.95 2026-12-31 | 4.9 – 5.01 | 3 | -11.55% | -11.55% | -11.55% | 3 / 0 | $690.6M |
| AAPG Ascentage Pharma Group International American Depository Shares | -1.52 2026-12-31 | -2.5 – -0.43 | 5 | — | — | — | 0 / 5 | $861.06M |
| ABOS Acumen Pharmaceuticals Inc. Common Stock | -1.58 2026-12-31 | -1.76 – -1.32 | 3 | — | — | — | 2 / 0 | $0 |
| AGIO Agios Pharmaceuticals Inc. Common Stock | -6.14 2026-12-31 | -7.21 – -5.5 | 7 | — | — | — | 0 / 1 | $130.56M |
| AMLX Amylyx Pharmaceuticals Inc. Common Stock | -1.43 2026-12-31 | -1.59 – -1.27 | 7 | — | — | — | 3 / 4 | $0 |
| ARWR Arrowhead Pharmaceuticals Inc. Common Stock | -3.08 2026-09-30 | -3.82 – -1.85 | 11 | — | — | — | 2 / 0 | $442.33M |
| ATYR aTyr Pharma Inc. Common Stock | -0.56 2026-12-31 | -0.76 – -0.43 | 8 | — | — | — | 4 / 0 | $0 |
| AVBP ArriVent BioPharma Inc. Common Stock | -4.09 2026-12-31 | -4.62 – -3.62 | 11 | — | — | — | 0 / 2 | $0 |
| BBIO BridgeBio Pharma Inc. Common Stock | -2.14 2026-12-31 | -2.58 – -1.5 | 8 | — | — | — | 3 / 1 | $961.16M |
| BNTC Benitec Biopharma Inc. Common Stock | -1 2026-06-30 | -1.07 – -0.96 | 6 | — | — | — | 4 / 0 | $0 |
| CBIO Crescent Biopharma Inc. Common Stock | -2.49 2026-12-31 | -2.73 – -2.22 | 3 | — | — | — | 0 / 1 | $2.08M |
| CNTB Connect Biopharma Holdings Limited Ordinary Shares | -1.05 2026-12-31 | -1.14 – -0.8 | 5 | — | — | — | 4 / 0 | $41.83M |
| CRBP Corbus Pharmaceuticals Holdings Inc. Common Stock | -4.57 2026-12-31 | -5.7 – -3.31 | 10 | — | — | — | 4 / 4 | $1.11M |
| CRNX Crinetics Pharmaceuticals Inc. Common Stock | -4.62 2026-12-31 | -5.28 – -3.48 | 13 | — | — | — | 0 / 1 | $68.49M |
| CRVS Corvus Pharmaceuticals Inc. Common Stock | -0.71 2026-12-31 | -0.8 – -0.65 | 4 | — | — | — | 0 / 3 | $0 |
| DERM Journey Medical Corporation Common Stock | 0.07 2026-12-31 | -0.05 – 0.4 | 4 | — | — | — | 0 / 0 | $82.62M |
| ELDN Eledon Pharmaceuticals Inc. Common Stock | -0.87 2026-12-31 | -0.92 – -0.77 | 4 | — | — | — | 2 / 0 | $0 |
| ENTA Enanta Pharmaceuticals Inc. Common Stock | -1.88 2026-09-30 | -2.27 – -1.39 | 4 | — | — | — | 2 / 1 | $66.34M |
| EPRX Eupraxia Pharmaceuticals Inc. Common Stock | -0.98 2026-12-31 | -1.17 – -0.78 | 8 | — | — | — | 0 / 5 | $0 |
| FENC Fennec Pharmaceuticals Inc. Common Stock | 0.3 2026-12-31 | 0.18 – 0.47 | 5 | -2.95% | — | -52.87% | 4 / 2 | $69.83M |
| FPI Farmland Partners Inc. Common Stock | 0.18 2026-12-31 | 0.16 – 0.21 | 3 | — | — | — | 2 / 0 | $44.95M |
| FRMI Fermi Inc. Common Stock | -0.34 2026-12-31 | -0.69 – -0.11 | 4 | — | — | — | 1 / 2 | $52.44M |
| III Information Services Group Inc. Common Stock | 0.37 2026-12-31 | 0.35 – 0.4 | 3 | 0.00% | — | +12.12% | 3 / 0 | $252.05M |
| IMMX Immix Biopharma Inc. Common Stock | -0.71 2026-12-31 | -0.87 – -0.57 | 8 | — | — | — | 3 / 1 | $0 |
| IONS Ionis Pharmaceuticals Inc. Common Stock | -2.65 2026-12-31 | -2.69 – -2.62 | 4 | — | — | — | 1 / 0 | $926.6M |
| IPHA Innate Pharma S.A. ADS | -0.55 2026-12-31 | -0.65 – -0.46 | 3 | — | — | — | 0 / 1 | $31.21M |
| KPTI Karyopharm Therapeutics Inc. Common Stock | -4.95 2026-12-31 | -6.03 – -3.58 | 3 | — | — | — | 1 / 0 | $138.21M |
| LBRX LB Pharmaceuticals Inc Common Stock | -3.35 2026-12-31 | -3.72 – -2.75 | 7 | — | — | — | 4 / 0 | $0 |
| LRMR Larimar Therapeutics Inc. Common Stock | -1.61 2026-12-31 | -1.82 – -1.43 | 8 | — | — | — | 2 / 0 | $0 |
| LXRX Lexicon Pharmaceuticals Inc. Common Stock | -0.16 2026-12-31 | -0.18 – -0.14 | 5 | — | — | — | 2 / 0 | $38.17M |
| LYEL Lyell Immunopharma Inc. Common Stock | -7.64 2026-12-31 | -8.62 – -6.87 | 8 | — | — | — | 1 / 0 | $11.71K |
| MANE Veradermics Incorporated Common Stock | -2.84 2026-12-31 | -3.35 – -2.1 | 5 | — | — | — | 0 / 1 | $0 |
| MIST Milestone Pharmaceuticals Inc. Common Shares | -0.83 2026-12-31 | -0.99 – -0.74 | 4 | — | — | — | 0 / 2 | $5.39M |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。